Searched for
SANOFI SHARES
Dividend alert! Last day to buy HDFC Bank, Tata Motors PV, 14 other stocks for dividends worth Rs 248Under SEBI's T+1 settlement cycle, investors must purchase a company's shares at least one trading day before the record date to ensure the...- Dividends and bonus issues: 31 stocks turning ex-record date this week. Do you own any?As many as 31 companies, including HDFC Bank, Tata group firms and Brigade Enterprises, will turn ex-record date for dividends and bonus is...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- AI coding startup Cursor, courted by SpaceX, picks London as European hubElon Musk's SpaceX, which is readying for a closely watched IPO this week, said in April it had secured an option to either acquire code-...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
- Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...
- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- Hot Stocks: Brokerage view on Paytm, Havells, Sanofi and TCSIIFL downgraded Sanofi India to Reduce from ADD earlier with a target price of Rs 8,125. The stock continues to underperform domestic marke...
- Sanofi trial failure ends development of breast cancer treatment amcenestrantA trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an ...
- Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
- Sanofi India Q3 results: Co posts net profit at Rs 530 croreSanofi India board in its meeting held on July 27 had approved a transaction for slump sale and transfer of its nutraceuticals business to ...
- Sanofi India shares hit 52-week high on Q4 resultsThe stock witnessed similar movement on the NSE as well, where it opened at 7,549.95.
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...
- Genzyme board rejects Sanofi $69-a-share offerBiotech firm Genzyme Corp. says its board of directors is rejecting Sanofi-Aventis SA's $69 a share offer and recommending Genzyme sharehol...
- Zentiva recommends shareholders reject Sanofi Aventis' bidThe board of Czech generic drugs maker Zentiva N.V. said it has recommended that its shareholders reject a takeover offer from French pharm...
- Plavix copies hit Sanofi-Aventis, net drops 12%Sanofi-aventis reported a 12% drop in third-quarter profit on Tuesday, citing the loss of top-selling blood thinner Plavix to generic compe...
Load More
